ArticleEye (London, England)2025

One-year outcomes of faricimab versus aflibercept treatment for polypoidal choroidal vasculopathy: a comparative study.

Jaejin Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.